Tilray Brands (TLRY) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
13 Apr, 2026Executive summary
Achieved record Q2 net revenue of $218 million, up 3% year-over-year, with strong international cannabis and Canadian adult-use growth, surpassing analyst expectations despite industry headwinds.
Operating loss narrowed to $22.3 million from $42.2 million in the prior year, with net loss improving by $41.8 million to $(43.5) million and adjusted net loss per share improving to $(0.02).
Ended the quarter with $292 million in cash and marketable securities, achieving a net cash position of nearly $30 million.
Diversified operations across cannabis, beverage, and wellness, with leading market positions in Canada and significant presence in the U.S. and Europe.
Completed a one-for-ten reverse stock split effective December 2, 2025.
Financial highlights
Net revenue for Q2 was $217.5 million, driven by international cannabis and distribution, with Canadian adult-use revenue up 6% year-over-year.
Cannabis net revenue reached $67.5 million, beverage net revenue was $50.1 million (down 21% year-over-year), distribution net revenue was $85.3 million (up 26%), and wellness net revenue was $14.6 million.
Gross profit was $57.5 million with a gross margin of 26%; cannabis gross margin increased to 39%, beverage 31%, distribution 13%, and wellness 32%.
Net loss for the quarter was $43.5 million, a significant improvement from $85.3 million in the prior year.
Cash flow used in operations improved to $8.5 million from $40.7 million last year.
Outlook and guidance
Reaffirmed full-year 2026 adjusted EBITDA guidance of $62 million to $72 million.
Anticipates continued growth in international cannabis and distribution, with spring product resets expected to benefit beverage revenue and margins in Q4.
Positioned to capitalize on U.S. cannabis rescheduling and global regulatory shifts, with readiness to scale medical cannabis operations.
Ongoing focus on SKU rationalization, geographic and distributor optimization, and synergy realization in the beverage segment.
Latest events from Tilray Brands
- Record Q3 revenue, strong cannabis growth, and improved profitability with BrewDog acquisition.TLRY
Q3 20269 Apr 2026 - Acquisition creates a $500M global craft beverage platform and accelerates international growth.TLRY
M&A announcement2 Mar 2026 - Balanced growth across cannabis, beverages, and distribution, with innovation and efficiency focus.TLRY
TD Cowen 9th Annual Future of the Consumer Conference3 Feb 2026 - Record revenue and EBITDA growth, margin gains, and strong outlook for continued expansion.TLRY
Q4 20242 Feb 2026 - Q1 revenue hit $200M (+13% YoY), led by beverage growth and margin gains, with net loss improvement.TLRY
Q1 202519 Jan 2026 - Q2 revenue hit $211M (+9% YoY), with margin gains and Project 420 synergies advancing.TLRY
Q2 202510 Jan 2026 - Diversified global platform drives growth in cannabis, beverage, and wellness with strong financials.TLRY
Investor Presentation8 Jan 2026 - Record Q1 revenue and return to profitability driven by cannabis and distribution growth.TLRY
Q1 202622 Dec 2025 - Proxy covers director election, auditor ratification, pay, and board declassification proposals.TLRY
Proxy Filing2 Dec 2025